Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tem

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound

Revisit Tempus AI after its post-earnings drop: Q4 growth vs. acquisition lift, 2026 EBITDA inflection guidance, dataset scale, and analyst targets.

MarketBeat

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building

Tempus AI posted an 83% revenue jump and raised guidance, yet shares fell. See analyst targets, institutional buying, margin trends, and key risks.

MarketBeat

Tempus AI: Volatility Equates to Opportunity in AI Leader

Tempus AI is well-positioned to accelerate growth as its investments in healthcare-focused AI pay off. Analysts are raising their targets.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Tempus AI Q3 Highlights: Cathie Wood-, Nancy Pelosi-Owned AI Stock Raises Guidance

AI company Tempus AI (NASDAQ:TEM) reported third-quarter financial results Tuesday after market close.

Benzinga

Ark Invest Dumps AMD Stock, Doubles Down On Chinese Tech Giants Alibaba And Baidu

On Thursday, Cathie Wood‘s Ark Invest made significant trades involving Alibaba Group Holding Ltd (NYSE:BABA), Baidu Inc (NASDAQ:BIDU), Advanced Micro Devices Inc (NASDAQ:AMD), and Tempus AI Inc (NASDAQ:TEM). These trades reflect Ark’s strategic positioning in the tech sector, with purchases and sales across multiple funds.

Benzinga

Tempus AI Shares Are Trading Higher Monday: What's Going On?

Tempus AI (NASDAQ:TEM) shares are trading higher Monday after the company announced its subsidiary, Ambry Genetics, published a peer reviewed study in Genetics in Medicine.

Benzinga

IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership

Whitehawk Therapeutics Inc. (NASDAQ:WHWK) dropped 8.81% in after-hours trading Thursday, closing at $2.38, after announcing a multi-year collaboration with Tempus AI.

Benzinga

Tempus AI Hits $100—Are Shares Due for a Pullback?

After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction.

MarketBeat

Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025

Investors who followed the stock market disclosures from former House Speaker Nancy Pelosi would have seen significant returns, as an investment in the artificial intelligence health company Tempus AI Inc. (NASDAQ:TEM) has surged in value.

Benzinga

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall

Tempus AI Inc (NASDAQ:TEM) has become one of 2025's most dramatic comeback stories. The stock soared past $100 this week, marking a new 52-week high and sending the market buzzing about the AI-powered cancer diagnostics company's growth prospects. Investors are taking note as the stock climbs amid recent FDA clearances…

Benzinga

Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock

Tempus AI Inc. (NASDAQ:TEM) shares are trending on Thursday.

Benzinga

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?

Shares of Tempus AI Inc (NASDAQ:TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here’s what investors need to know.

Benzinga

Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

3 Healthcare Stocks Using AI to Drive Growth

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

Benzinga

Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Worth $11 Million, Dumps AMD And This AI Stock (CORRECTED)

Editor’s Note: The story's headline has been updated to correct a typo.

Benzinga

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

On Tuesday, Cathie Wood-led Ark Invest made a notable decision by selling shares of Tempus AI Inc. (NASDAQ:TEM), marking a significant move in their investment strategy.

Benzinga

Tempus AI (TEM) Stock Is Rising Monday: What's Going On?

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Monday morning after the company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

3 Big Short Interest Names With Bullish Setups

HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot.

Benzinga

Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA), Pony AI Inc (NASDAQ:PONY) and Baidu Inc (NASDAQ:BIDU). These trades reflect Ark’s strategic positioning in the tech and AI sectors.

Barchart

This AI Stock Has More Than Doubled in 2025. Is It a Buy?

After a remarkable triple-digit surge so far in 2025, is now the time to buy the shares of this AI stock?

Benzinga

Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares of Tempus AI Inc. (NASDAQ:TEM). Additionally, Ark purchased Figma Inc. (NYSE:FIG) stock, reflecting strategic adjustments in its investment portfolio.

Benzinga

What's Going On With Tempus AI Stock Monday?

Tempus AI Inc (NASDAQ:TEM) stock is trading marginally lower on Monday, showing little movement after a 7% gain last week. On Friday, HC Wainwright Co. analyst Yi Chen reiterated a Buy rating on the artificial intelligence and precision medicine company, raising the price target to $98 from $90.

Benzinga

Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock

On Thursday, Cathie Wood-led Ark Invest executed significant trades involving Tempus AI Inc. (Pre-Reincorporation)(NASDAQ:TEM), Bullish (NYSE:BLSH), Amazon.com Inc. (NASDAQ:AMZN), and Figma Inc. (NYSE:FIG).

Benzinga

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

On Thursday, Tempus AI, Inc. (NASDAQ:TEM) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alibaba Group Holding Ltd

148 stories

ARKK

147 stories

Advanced Micro Devices, Inc

143 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.